Blair William & Co. IL reduced its holdings in shares of Ryan Specialty Holdings Inc. (NYSE:RYAN – Free Report) by 5.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,660,791 shares of the company’s stock after selling 153,404 shares during the period. Blair William & Co. IL owned approximately 1.01% of Ryan Specialty worth $149,962,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Ameritas Investment Partners Inc. grew its stake in shares of Ryan Specialty by 0.9% during the third quarter. Ameritas Investment Partners Inc. now owns 21,119 shares of the company’s stock worth $1,190,000 after acquiring an additional 185 shares during the last quarter. MAI Capital Management increased its holdings in shares of Ryan Specialty by 65.3% during the second quarter. MAI Capital Management now owns 476 shares of the company’s stock valued at $32,000 after acquiring an additional 188 shares in the last quarter. Baker Tilly Wealth Management LLC raised its position in shares of Ryan Specialty by 5.6% in the 3rd quarter. Baker Tilly Wealth Management LLC now owns 3,595 shares of the company’s stock valued at $203,000 after purchasing an additional 192 shares during the last quarter. ProShare Advisors LLC boosted its stake in Ryan Specialty by 5.2% in the 2nd quarter. ProShare Advisors LLC now owns 4,772 shares of the company’s stock worth $324,000 after purchasing an additional 238 shares in the last quarter. Finally, Securian Asset Management Inc. boosted its stake in Ryan Specialty by 2.9% in the 3rd quarter. Securian Asset Management Inc. now owns 8,438 shares of the company’s stock worth $476,000 after purchasing an additional 241 shares in the last quarter. 84.82% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of research analysts have issued reports on the stock. Barclays cut their price target on shares of Ryan Specialty from $58.00 to $52.00 and set an “overweight” rating on the stock in a research note on Friday, February 13th. Piper Sandler lowered their price objective on shares of Ryan Specialty from $58.00 to $43.00 and set a “neutral” rating for the company in a research note on Friday, February 13th. UBS Group dropped their price objective on shares of Ryan Specialty from $71.00 to $65.00 and set a “buy” rating on the stock in a report on Tuesday, February 17th. Wells Fargo & Company cut their target price on Ryan Specialty from $63.00 to $56.00 and set an “overweight” rating on the stock in a research report on Friday, February 13th. Finally, The Goldman Sachs Group set a $61.00 target price on Ryan Specialty in a research note on Wednesday, January 7th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, five have given a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $56.87.
Insider Buying and Selling at Ryan Specialty
In other Ryan Specialty news, Director Patrick G. Ryan, Jr. purchased 25,500 shares of the stock in a transaction on Monday, February 23rd. The shares were bought at an average cost of $39.96 per share, with a total value of $1,018,980.00. Following the completion of the acquisition, the director owned 428,295 shares in the company, valued at $17,114,668.20. This trade represents a 6.33% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Timothy William Turner sold 129,570 shares of the stock in a transaction dated Friday, December 12th. The stock was sold at an average price of $53.61, for a total value of $6,946,247.70. Following the sale, the chief executive officer directly owned 12,553 shares in the company, valued at $672,966.33. This represents a 91.17% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 52.21% of the stock is currently owned by corporate insiders.
Ryan Specialty Stock Performance
RYAN opened at $39.81 on Friday. Ryan Specialty Holdings Inc. has a 12-month low of $37.29 and a 12-month high of $77.16. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 2.62. The firm has a market capitalization of $10.52 billion, a PE ratio of 94.79, a P/E/G ratio of 1.02 and a beta of 0.65. The firm has a 50 day moving average of $46.17 and a two-hundred day moving average of $51.98.
Ryan Specialty (NYSE:RYAN – Get Free Report) last announced its quarterly earnings data on Thursday, February 12th. The company reported $0.45 EPS for the quarter, missing the consensus estimate of $0.50 by ($0.05). The business had revenue of $751.21 million for the quarter, compared to analyst estimates of $777.43 million. Ryan Specialty had a net margin of 7.02% and a return on equity of 46.41%. The business’s revenue was up 13.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.45 earnings per share. On average, analysts anticipate that Ryan Specialty Holdings Inc. will post 2.29 EPS for the current year.
Ryan Specialty Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 10th. Investors of record on Tuesday, February 24th will be given a dividend of $0.13 per share. This is a boost from Ryan Specialty’s previous quarterly dividend of $0.12. This represents a $0.52 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date is Tuesday, February 24th. Ryan Specialty’s payout ratio is presently 123.81%.
About Ryan Specialty
Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.
Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.
Read More
- Five stocks we like better than Ryan Specialty
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Unlocked: Elon Musk’s Next Big IPO
- Elon Musk already made me a “wealthy man”
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.
